Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Dec 1:38:e386723.
doi: 10.1590/acb386723. eCollection 2023.

Lacticaseibacillus casei decrease long-chain fatty acids and most substances in an experimental model of intestinal mucositis

Affiliations

Lacticaseibacillus casei decrease long-chain fatty acids and most substances in an experimental model of intestinal mucositis

Stphannie Jamyla de Araújo Barbosa et al. Acta Cir Bras. .

Abstract

Purpose: To evaluate the long-chain fatty acid and major compounds levels in the feces after prophylactic oral use of Lacticaseibacillus casei in an experimental model of intestinal mucositis.

Methods: Fifteen Swiss mice were randomly divided into three groups (n=5/group): The negative or positive control groups (n = 5) received saline orally for 18 days and an the intraperitoneal (i.p.) of saline or 5 Fluorouracil (450 mg/kg) in 15th day, respectability. L. casei group received oral concentration of L. casei (1x109 CFU/mL) for 18 days, the i.p. injection of 5-fluorouracil (450 mg/kg) in 15th days. Tissue samples from colon and each small intestine segment were collected for histopathological analysis. Stool samples were collected. Fecal composition of long-chain fatty acids and sterols were analysed by gas chromatography-mass spectrometry on the 15th and the 18th day.

Results: The mucosa layer of all small intestine segments of animals from L. casei showed well preserved epithelium and glands, without necrosis signs, but Goblet cells number decreased. Several long-chain fatty acids and sterols have been identified before and after in the groups. L. casei administration after 5-FU treatment reduced concentrations of linoleic acid (18:2) (p < 0.001) and oleic acid (18:1) (p < 0.001) in feces.

Conclusions: L. casei prevented the mucosal damage associated with 5-FU-induced intestinal mucositis reduced long-chain fatty acid levels in the feces.

PubMed Disclaimer

Conflict of interest statement

Conflict of interest: Nothing to declare.

Figures

Figure 1
Figure 1. Description of histological characteristics of duodenum, jejunum, ilium and colon in CN, CP and L. casei group. CN: Histopathological of duodenum, jejunum, ileum and colon shows well preserved mucosa, with long villi (black arrows) and well preserved crypts. The submucosa is intact, with normal submucosal glands and no signs of inflammatory infiltration (yellow arrow) or necrosis (green arrow). Several goblet cells were found (red arrow), especially in the Colon. CP: 5-fluorouracil (5-FU)-injury group showed clear signs of damage, with short villi and small crypts and little evidence of goblet cells in duodenum’s mucosa. The submucosa is also injured, with signs of inflammatory infiltration and few submucosal glands. Both jejunum and ileum’s mucosa showed shortened villi and poorly preserved crypts in 5-FU-injured group, and just a few goblet cells were found in jejunum. Submucosal jejunum layer was heavily infiltrated by inflammatory cells (yellow arrow), with some signs of necrosis (green arrow). Short crypts were found in the colon’s mucosa, as well as necrosis foci. L. casei: no sign of inflammatory infiltrate was found in the submucosa layer of the colon. L. casei protected the colon and some small intestine segments against 5-FU-induced injury. Although inflammatory infiltration was still present throughout the whole small intestine submucosal layer (yellow arrow), the mucosa layer of all small intestine segments showed well preserved epithelium and glands, without necrosis signs. Goblet cells number decreased. No signs of injury were found in the colon segments.
Figure 2
Figure 2. Gas chromatography mass spectrometry analysis identified the composition of long-chain fatty acids day 18 for the negative control (CN), positive control (CP) and Lacticaseibacillus casei groups. Lacticaseibacillus casei decrease oleic acid (p < 0.001) and linoleic acid (p < 0.001) after induction of intestinal mucositis by 5-fluorouracil.

References

    1. Elting LS, Cooksley C, Chambers M, Cantor SB, Manzullo E, Rubenstein EB. The burdens of cancer therapy: Clinical and economic outcomes of chemotherapy-induced mucositis. Cancer. 2003;98(7):1531–1539. doi: 10.1002/cncr.11671. - DOI - PubMed
    1. Bowen JM, Gibson RJ, Coller JK, Blijlevens N, Bossi P, Al-Dasooqi N, Bateman EH, Chiang K, Mooij C, Mayo B, Stringer AM, Tissing W, Wardill HR, van Sebille, Ranna V, Vaddi A, Keefe DMK, Lalla RV, Cheng KKF, Elad S. Systematic review of agents for the management of cancer treatment-related gastrointestinal mucositis and clinical practice guidelines. Support Care Cancer. 2019;27(10):4011–4212. doi: 10.1007/s00520-019-04892-0. - DOI - PubMed
    1. Sanders ME, Heimbach JT, Pot B, Tancredi DJ, LenoirWijnkoop I, Lähteenmäki-Uutela A, Gueimonde M, Bañares S. Health claims substantiation for probiotic and prebiotic products. Gut Microbes. 2011;2(3):127–133. doi: 10.4161/gmic.2.3.16174. - DOI - PubMed
    1. Hill C, Guarner F, Reid G, Gibson GR, Merenstein DJ, Pot B, Morelli L, Canani RB, Flint HJ, Salminen S, Calder PC, Sanders ME. Expert consensus document: The international scientific association for probiotics and prebiotics consensus statement on the scope and appropriate use of the term probiotic. Nat Rev Gastroenterol Hepatol. 2014;11(8):506–514. doi: 10.1038/nrgastro.2014.66. - DOI - PubMed
    1. Pujo J, Petitfils C, Le Faouder P, Eeckhaut V, Payros G, Maurel S, Perez-Berezo T, Van Hul, Barreau F, Blanpied C, Chavanas S, Van Immerseel, Bertrand-Michel J, Oswald E, Dietrich G. Bacteria-derived long chain fatty acid exhibits anti-inflammatory properties in colitis. Gut. 2021;70(6):1088–1097. doi: 10.1136/gutjnl-2020-321173. - DOI - PubMed